William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
William Blair analyst Andy T. Hsieh downgraded Cardiff Oncology (NASDAQ: CRDF) from Outperform to Market Perform.The analyst comments: “After markets ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)